GFCR Grant Program (cancer clinical trial)
The Grant Program from the Gateway for Cancer Research funds early phase clinical trials for any type of cancer, conducted at renowned research institutions worldwide. Grants are typically 2-5 years in duration with award amounts from 200,000 to 1.5 million USD. Applicants are required to first submit a letter of intent (LOI). Eligible applicants will be given 4-5 weeks to complete their full application. The next LOI closing date is July 26, 2022.
Challenge: Clinical Trials
Create or sign in to your free account for more functionalities, including a full display of the eligibility criteria such as location and citizenship requirements.